Valuation Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 10:18:50 2024-12-05 am EST 5-day change 1st Jan Change
520.90 USD -1.51% Intraday chart for Thermo Fisher Scientific Inc. -1.37% -1.58%

Company Valuation: Thermo Fisher Scientific Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 130,270 184,605 262,925 216,998 205,083 202,293 - -
Change - 41.71% 42.43% -17.47% -5.49% -1.36% - -
Enterprise Value (EV) 1 145,623 196,015 293,318 242,962 231,923 228,114 222,575 215,836
Change - 34.6% 49.64% -17.17% -4.54% -1.64% -2.43% -3.03%
P/E ratio 35.4x 29.2x 34.3x 31.2x 34.4x 32.5x 29x 24.9x
PBR 4.38x 5.39x 6.45x 4.89x 4.39x 4.05x 3.7x 3.38x
PEG - 0.4x 1.6x -3.32x -2.8x 6.03x 2.4x 1.5x
Capitalization / Revenue 5.1x 5.73x 6.71x 4.83x 4.79x 4.73x 4.48x 4.18x
EV / Revenue 5.7x 6.08x 7.48x 5.41x 5.41x 5.33x 4.93x 4.46x
EV / EBITDA 22.3x 19.2x 22.6x 20.3x 21.3x 21.1x 19.3x 17x
EV / EBIT 24.4x 20.5x 24.2x 22.1x 23.6x 23.5x 21.4x 18.9x
EV / FCF 36x 28.8x 41.8x 35x 33.5x 32.7x 25.7x 22.6x
FCF Yield 2.78% 3.48% 2.39% 2.85% 2.99% 3.06% 3.89% 4.42%
Dividend per Share 2 0.76 0.88 1.04 1.2 1.4 1.492 1.598 1.735
Rate of return 0.23% 0.19% 0.16% 0.22% 0.26% 0.28% 0.3% 0.33%
EPS 2 9.17 15.96 19.46 17.63 15.45 16.28 18.27 21.27
Distribution rate 8.29% 5.51% 5.34% 6.81% 9.06% 9.16% 8.75% 8.15%
Net sales 1 25,542 32,218 39,211 44,915 42,857 42,813 45,111 48,443
EBITDA 1 6,537 10,214 12,969 11,971 10,878 10,800 11,531 12,675
EBIT 1 5,973 9,556 12,138 10,985 9,810 9,703 10,415 11,423
Net income 1 3,696 6,375 7,725 6,950 5,995 6,143 6,943 8,069
Net Debt 1 15,353 11,410 30,393 25,964 26,840 25,821 20,282 13,543
Reference price 2 324.87 465.78 667.24 550.69 530.79 528.87 528.87 528.87
Nbr of stocks (in thousands) 400,991 396,335 394,048 394,048 386,372 382,500 - -
Announcement Date 1/30/20 2/1/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

Add to a list
P/E ratio EV / Sales EV / EBITDA Yield (Y) Capi. ($)
32.48x5.33x21.12x+0.28%202B
91.78x23.48x57.25x-.--%196B
42.39x7.78x24.79x+0.48%171B
68.18x8.5x28.52x-.--%134B
24.43x2.96x13.93x+2.13%61.01B
32.09x6.93x22.72x-.--%43.76B
23.99x7.56x19.53x+2.56%43.2B
31.54x6.34x21.66x+0.66%39.98B
20.15x2.2x11.82x+0.13%37.93B
27.28x6.98x19.42x+0.89%36.08B
Average 39.43x 7.81x 24.08x +0.71% 96.47B
Weighted average by Cap. 49.60x 9.89x 29.27x +0.46%
See all sector valuations

Year-on-year evolution of the PER

evolution-chart THERMO-FISHER-SCIENTIFIC-

Historical PBR trend

evolution-chart THERMO-FISHER-SCIENTIFIC-

Evolution Enterprise Value / Sales

evolution-chart THERMO-FISHER-SCIENTIFIC-

Change in Enterprise Value/EBITDA

evolution-chart THERMO-FISHER-SCIENTIFIC-

Year-on-year evolution of the Yield

evolution-chart THERMO-FISHER-SCIENTIFIC-
  1. Stock Market
  2. Equities
  3. TMO Stock
  4. Valuation Thermo Fisher Scientific Inc.